Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 3/20 | 0.48 |
| ▸ | DRD3 | P35462 | 3/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.41 |
| ▸ | SRC | P12931 | 2/20 | 0.41 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25454993 | 0.93 | LSS (0.45) | LSSDRD2DRD3ATMFGFR1 | |
| SCHEMBL25455126 | 0.88 | LSS (0.46) | LSSDRD2DRD3FGFR1SRC | |
| SCHEMBL25455135 | 0.87 | LSS (0.41) | LSSDRD2DRD3ATMFGFR1 | |
| SCHEMBL25455130 | 0.84 | MCHR1 (0.46) | LSSDRD2DRD3FGFR1SRC | |
| SCHEMBL25455081 | 0.83 | LSS (0.41) | LSSDRD2DRD3ATMFGFR1 | |
| SCHEMBL25454983 | 0.83 | MCHR1 (0.47) | LSSFGFR1SRCALDH1A1 | |
| SCHEMBL25455021 | 0.83 | CA12 (0.47) | LSSDRD2DRD3ATMFGFR1 | |
| SCHEMBL25455084 | 0.82 | ESR1 (0.46) | FGFR1SRCALDH1A1 | |
| SCHEMBL25455120 | 0.81 | MCHR1 (0.46) | LSSFGFR1SRCALDH1A1 | |
| SCHEMBL25455139 | 0.81 | ESR1 (0.44) | LSSDRD2DRD3ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023079033-A1 | PHARMACEUTICAL COMPOSITION, ITS USE AS A DRUG AND NEW COMPOUNDS, ESPECIALLY FOR TREATING SARS-COV-2 INFECTION | Universite de Bordeaux (FR) | 2023-05-11 | — | — | WO | disclosed |
| EP-4176875-A1 | PHARMACEUTICAL COMPOSITION, ITS USE AS A DRUG AND NEW COMPOUNDS, ESPECIALLY FOR TREATING SARS-COV-2 INFECTION | Université de Bordeaux (FR) | 2023-05-10 | — | — | EP | disclosed |